BAIA
TEVA icon

Bel Air Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Bel Air Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$209K Hold
5,528
– – 0.03% 106
2013
Q2 		$217K Buy
+5,528
New +$215K 0.03% 107

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bel Air Investment Advisors's TEVA Position: Q3 2013 in Review

Bel Air Investment Advisors held its Teva Pharmaceuticals (TEVA) position steady in Q3 2013 at 5,528 shares worth $209K. The position accounts for 0.03% of the portfolio, ranked #106.

Bel Air Investment Advisors first reported a position in TEVA in Q2 2013 and has held it in 2 quarters since. The position peaked at $217K in Q2 2013. 705 funds tracked by Wall St. Rank hold TEVA as of Q3 2013.

  • Bel Air Investment Advisors held 5,528 shares of Teva Pharmaceuticals worth $209K as of Q3 2013.
  • Bel Air Investment Advisors left its Teva Pharmaceuticals share count unchanged in Q3 2013.
  • Teva Pharmaceuticals made up 0.03% of Bel Air Investment Advisors's portfolio in Q3 2013, its #106 holding.
  • Bel Air Investment Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 2 quarters since.
  • Bel Air Investment Advisors's Teva Pharmaceuticals position peaked at $217K in Q2 2013.
  • 705 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2013.

Based on Bel Air Investment Advisors's 13F filing for Q3 2013, filed 12 Nov 2013.